Related Experiment Video
Updated: Jun 20, 2026
07:04
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
Published on: September 16, 2018
Immunomodulator agent-related lymphoproliferative disorders.
Robert P Hasserjian1, Steve Chen, Sherrie L Perkins
1Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA. rhasserjian@partners.org
Summary
Immunomodulator agents, used for autoimmune diseases, can increase the risk of lymphoproliferative disorders (LPDs). This study examined 18 cases of these disorders, finding various lymphomas and atypical lymphoid proliferations linked to these therapies.
Area of Science:
- Immunology
- Oncology
- Pathology
Background:
- Immunomodulator agents, including monoclonal antibodies and receptor antagonists, have transformed autoimmune disease therapy.
- However, these agents, particularly anti-tumor necrosis factor alpha (TNFalpha) therapies, are associated with increased risks of lymphoproliferative disorders, infections, and vasculitis.
Purpose of the Study:
- To evaluate the clinicopathological features of 18 cases of immunomodulator agent-related lymphoproliferative disorders (IAR-LPD).
Main Methods:
- Retrospective analysis of 18 cases of IAR-LPD from multiple institutions.
- Clinicopathological evaluation including lymphoma classification and assessment of atypical lymphoid proliferations.
Main Results:
- The study identified 6 B-cell lymphomas, 2 T-cell lymphomas, 3 classical Hodgkin lymphomas, and 7 atypical lymphoid proliferations.
- Two atypical proliferations regressed upon discontinuation of immunomodulator therapy.
- Epstein-Barr virus (EBV) showed a strong association with B-cell and classical Hodgkin lymphomas.
Conclusions:
- A wide spectrum of lymphoid proliferations can arise following immunomodulator agent therapy.
- IAR-LPDs share features with other iatrogenic immunosuppression-associated lymphoproliferative diseases.
- Further research is needed to understand the interplay between immunomodulators, other immunosuppressants, and lymphomagenesis.
More Related Videos
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:15Secondary Lymphoid Organs
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...